US2005014715A1PendingUtilityA1

Inosine compounds and their use for treating or preventing an inflammation or reperfusion disease

Priority: Dec 2, 1998Filed: Aug 12, 2004Published: Jan 20, 2005
Est. expiryDec 2, 2018(expired)· nominal 20-yr term from priority
A61K 31/00Y02A50/30A61K 45/06C07H 19/16A61K 31/7076
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Inosine compounds, compositions comprising an inosine compound and methods for treating or preventing an inflammation disease or a reperfusion disease comprising administering an effective amount of an inosine compound to a patient in need thereof are disclosed.

Claims

exact text as granted — not AI-modified
1 - 9 . (canceled)  
     
     
         10 . A method for treating a reperfusion disease, comprising administering to a patient in need thereof an effective amount of a compound of formula I:  
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt thereof, wherein: 
 R 1  is C 2 -C 6  acyl, SO 3 H, P 2 O 6 H 3  or P 3 O 9 H 4 ; and  
 R 2 , R 3  and R 4  are independently H, C 2 -C 6  acyl, SO 3 H, PO 3 H 2 , P 2 O 6 H 3  or P 3 O 9 H 4 .  
 
     
     
         11 . The method of  claim 10 , wherein 
 R 1  is C 2 -C 6  acyl, SO 3 H, P 2 O 6 H 3 , P 3 O 9 H 4  or a pharmaceutically acceptable salt thereof; and    R 2 , R 3  and R 4  are H.    
     
     
         12 . The method of  claim 10 , wherein R 1  is —SO 3 H, or a pharmaceutically acceptable salt thereof.  
     
     
         13 . The method of  claim 10 , wherein R 1  is P 2 O 6 H 3 , or a pharmaceutically acceptable salt thereof.  
     
     
         14 . The method of  claim 10 , wherein R 1  is P 3 O 9 H 4 , or a pharmaceutically acceptable salt thereof.  
     
     
         15 . The method of  claim 10 , wherein R 1  is C 2 -C 6  acyl.  
     
     
         16 . The method of  claim 15 , wherein the C 2 -C 6  acyl is acetyl.  
     
     
         17 . The method of  claim 10 , wherein the reperfusion disease is hemorrhagic shock, septic shock, sepsis, a disease caused by solid organ transplantation, cadiopulmonary bypass surgery, compartment syndrome, crush injury, splanchnic ischemia-reperfusion, myocardial infarction and stroke.  
     
     
         18 - 75 . (canceled)  
     
     
         76 . The method of  claim 10 , wherein R 2 , R 3 , and R 4  are each hydrogen, and R 1  is —SO 3   − Na + .

Join the waitlist — get patent alerts

Track US2005014715A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.